Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584.SZ

24.7 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 506.54526.465578.315706.296924.538711.908455.035280.828220.993197.655169.502147.953
Cost of Revenue 129.961130.017109.01171.561187.15598.0595.28891.20285.10579.34574.06169.979
Gross Profit 376.579396.448469.305534.734737.383613.858359.747189.625135.889118.3195.44177.974
Gross Profit Ratio 0.7430.7530.8120.7570.7980.8620.7910.6750.6150.5990.5630.527
Reseach & Development Expenses 44.56818.21721.69731.87636.09837.53431.3523.62718.22715.94912.5110
General & Administrative Expenses 23.81516.50218.86112.52814.2614.0979.1117.2645.6815.8665.41724.122
Selling & Marketing Expenses 241.596268.706342.878385.432531.195437.956218.73185.85750.2742.47630.87523.156
SG&A 283.888285.208361.738397.959545.455452.053227.84293.12155.95148.34236.29247.278
Other Expenses -4.681-1.325305.282-1.16-0.105-0.548-1.2920.6492.2461.1541.363-0.187
Operating Expenses 333.138351.712435.202462.967614.653513.42280.753134.48988.43576.38857.60348.642
Operating Income 43.44130.101331.362.506114.26696.51777.58352.07645.4740.05237.39630.128
Operating Income Ratio 0.0860.0570.5730.0880.1240.1360.170.1850.2060.2030.2210.204
Total Other Income Expenses Net -5.752-1.325-0.853-1.16-0.105-0.548-1.2920.3831.973-0.2681.363-0.38
Income Before Tax 37.68928.776330.44761.346114.16195.96976.2952.4647.44439.78538.75929.748
Income Before Tax Ratio 0.0740.0550.5710.0870.1230.1350.1680.1870.2150.2010.2290.201
Income Tax Expense 1.374-3.34845.6156.8217.00312.74610.697.2237.1155.5715.4714.156
Net Income 36.31632.449285.87855.2397.25883.22365.60145.23640.32934.21433.28725.592
Net Income Ratio 0.0720.0620.4940.0780.1050.1170.1440.1610.1820.1730.1960.173
EPS 0.30.272.380.460.810.690.560.50.450.380.370
EPS Diluted 0.30.272.380.460.810.690.560.50.450.380.370
EBITDA 97.00192.496377.013102.399150.865118.37295.58968.53660.68453.26543.16627.881
EBITDA Ratio 0.1910.1760.6520.1450.1630.1660.210.2440.2750.2690.2550.188